This inventor holds 1 USPTO granted patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Vakzine Projekt Management Gmbh. Active years: 2018.
Company Filing History:
1 out of 1,330 
1 out of 9 Years Active: 2018
Title: Christine Desel: Innovator in Vaccine Development
Introduction
Christine Desel is a prominent inventor based in Nuremberg, Germany. She has made significant contributions to the field of vaccine development, particularly through her innovative work in recombinant cell technology.
Latest Patents
Christine holds one patent related to her invention, which involves a recombinant cell for use as a vaccine. This invention showcases her commitment to advancing medical science and improving public health.
Career Highlights
Throughout her career, Christine has worked with notable organizations, including Vakzine Projekt Management GmbH and the Max Planck Society for the Advancement of Science. Her experience in these institutions has allowed her to collaborate with leading experts in the field.
Collaborations
Christine has had the opportunity to work alongside esteemed colleagues such as Stefan H. E. Kaufmann and Silke Bandermann. Their collaborative efforts have furthered research and development in vaccine technology.
Conclusion
Christine Desel's contributions to vaccine innovation highlight her role as a key figure in the scientific community. Her work continues to inspire advancements in healthcare and vaccine development.